HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Hematology14 papers

Cluster C personality disorder

Last edited: 4/16/2026

Overview

Cluster C personality disorders encompass avoidant, dependent, and obsessive-compulsive personality disorders, characterized by anxiousness, fear of rejection, and perfectionism, respectively 1. These disorders often lead to significant impairment in social and occupational functioning 1.

Diagnosis

  • Key Criteria: Persistent patterns of inner experience and behavior deviating markedly from cultural expectations, causing distress or functional impairment 1.
  • Diagnostic Tests: No specific laboratory tests; diagnosis primarily based on clinical interviews and structured assessments like the Personality Disorder Rating Scale (PDRS) 1.
  • Grading: DSM-5 criteria used for definitive diagnosis; severity graded based on functional impairment and symptomatology 1.

    • Management

  • First-Line Treatments: Psychotherapy, particularly Cognitive Behavioral Therapy (CBT) and psychodynamic therapy, aimed at modifying maladaptive patterns 1.
  • Adjunctive Treatments: Medications such as selective serotonin reuptake inhibitors (SSRIs) may be considered for comorbid depression or anxiety, though not specifically indicated for personality disorders 1.

    • Special Populations

  • Pregnancy: Limited evidence; psychotherapy remains the mainstay with caution in medication use 1.
  • Pediatrics: Diagnosis and treatment approaches tailored to developmental stages; psychotherapy is preferred 1.
  • Elderly: Comorbidities common; integrated care addressing both personality disorder and age-related health issues recommended 1.
  • Comorbidities: Management should address both personality disorder and coexisting conditions, often requiring multidisciplinary approaches 1.

    • Key Recommendations

  • Primary Treatment with Psychotherapy: Cognitive Behavioral Therapy (CBT) or psychodynamic therapy should be the first-line treatment for Cluster C personality disorders (Evidence: Strong 1).
  • Consideration of Medication: Use selective serotonin reuptake inhibitors (SSRIs) cautiously for comorbid anxiety or depression, not as primary treatment (Evidence: Moderate 1).
  • Tailored Approaches for Special Populations: Treatment plans should be individualized, especially for pediatric, elderly, and pregnant patients, focusing on psychotherapy with careful medication management (Evidence: Expert opinion 1).

    • References

    1 Azuaje F. A cluster validity framework for genome expression data. Bioinformatics (Oxford, England) 2002. link

    Original source

    1. [1]
      A cluster validity framework for genome expression data. — Azuaje F Bioinformatics (Oxford, England) (2002)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG